Skip to main content
logo
Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.3601
-0.0001 (-0.03%)
Aug 28, 2026, 1:42 PM EDT - Market open

Silexion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Market Capitalization
26342--
Market Cap Growth
-52.01%86.31%-92.33%---
Enterprise Value
1-1641--
Last Close Price
0.3619.20301.5014647.49--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
PB Ratio
45.522.31-0.8113.99--
P/TBV Ratio
45.522.31----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Debt / Equity Ratio
32.050.78-1.130.06--
Net Debt / Equity Ratio
-18.61-1.52-0.83-1.47-1.13-0.98
Net Debt / EBITDA Ratio
0.060.34-0.260.950.581.68
Net Debt / FCF Ratio
0.070.37-0.390.970.991.75
Quick Ratio
0.562.170.342.093.6410.47
Current Ratio
0.942.410.642.273.8510.64
Return on Equity (ROE)
-----116.66%-
Return on Assets (ROA)
--144.28%-193.54%--62.13%-
Return on Capital Employed (ROCE)
-5232.20%-261.00%1904.70%-153.00%-195.10%-58.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Earnings Yield
-696.92%-198.43%-510.32%-11.77%--
FCF Yield
-620.73%-180.37%-261.26%-10.82%--
SEC Filings: 10-K · 10-Q